Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
The Best Computer games for Multiplayer Fun - 2Picking the Right Home Machines: A Commonsense Aide
- 3IDF uncovers 7 km.-long Gaza terror tunnel where Hamas held Hadar Goldin
- 4China bans storing cremated remains in empty 'bone ash apartments'
- 5California warns of death cap mushrooms outbreak resulting in 3 deaths
- This Miraculous, Cliff-Perched Town In The South Of France Is A Sacred European Gem
- Vote In favor of Your Favored Kind Of Tea
- Report: Thailand strikes deal with Iran for safe passage of Hormuz
- San Francisco mayor says city in talks to bring pandas back to zoo ahead of trip to Asia
- Top 10 Books That Will Have an impact on Your Viewpoint
- Longtime United Launch Alliance CEO Tory Bruno resigns from space company. 'Finished the mission I came to do.'
- An Investigate of 6 Creative Specialty Mixed drinks
- Iranian naval commander Alireza Tangsiri killed in attack, says Israel
- Figure out How to Store Your Gold Ventures: A Thorough Aide safely
